I keep tell myself that i have better odds dumping more and more $$ each week or month into RVX that playing the Lottery, Lets assume the phase 3 trial has a 70 to 80% of success , thats before the post hoc analysis from the company verifying the MACE results , With the possibility of success of 1 of the orphan drug indication that initself could be worth $2 or 3 billion can we imagine what a succcessful Betonmace Phase 3 trial is worth, At least 10 billion market cap ,......RVX is turning itsel; into an exciting technology company,